Abstract
Myasthenia gravis (MG) primarily affects skeletal muscle through the production of autoantibodies against the nicotinic acetylcholine receptor in the motor endplates; in addition, heart muscle is an autoimmune target. We describe 2 illustrative cases of myasthenia gravis (MG)-related cardiomyopathy. The first case is a 63-year-old man treated for the decreased left ventricular systolic function and the positive results of autoantibody against striational proteins. The self-discontinuation of immunosuppressive agents was suggested to result in acute decompensated heart failure with serum levels of cardiac troponin I of 0.461 ng/mL and death.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
